Pinnacle Associates’s Antares Pharma, Inc. ATRS Stock Holding History

Pinnacle Associates’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-65,823	Closed	-$270K	–	804
2022 Q1	$270K	Hold	65,823	–	–	﹤0.01%	694
2021 Q4	$235K	Hold	65,823	–	–	﹤0.01%	728
2021 Q3	$240K	Hold	65,823	–	–	﹤0.01%	692
2021 Q2	$287K	Sell	65,823 -850	-1%	-$3.46K	0.01%	655
2021 Q1	$274K	Hold	66,673	–	–	0.01%	640
2020 Q4	$266K	Hold	66,673	–	–	0.01%	621
2020 Q3	$180K	Buy	66,673 +1,000	+2%	+$2.77K	﹤0.01%	645
2020 Q2	$181K	Sell	65,673 -18,732	-22%	-$52.3K	﹤0.01%	642
2020 Q1	$199K	Buy	84,405 +36,615	+77%	+$125K	0.01%	609
2019 Q4	$225K	Sell	47,790 -12,450	-21%	-$50.9K	﹤0.01%	652
2019 Q3	$202K	Hold	60,240	–	–	﹤0.01%	669
2019 Q2	$198K	Buy	+60,240	New	+$174K	﹤0.01%	673

Other funds holding ATRS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Pinnacle Associates's ATRS Position: Q2 2022 in Review

Pinnacle Associates sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 65,823 shares — an estimated $270K sold.

Pinnacle Associates first reported a position in ATRS in Q2 2019 and held it in 12 quarters. The position peaked at $287K in Q2 2021. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

Pinnacle Associates reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
Pinnacle Associates sold 65,823 Antares Pharma, Inc. shares in Q2 2022, an estimated $270K.
Pinnacle Associates first reported a position in Antares Pharma, Inc. in Q2 2019 and held it in 12 quarters.
Pinnacle Associates's Antares Pharma, Inc. position peaked at $287K in Q2 2021.
1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Pinnacle Associates's 13F filing for Q2 2022, filed 2 Aug 2022.